Awidi A S, Tarawneh M S, Abu Khalaf M S, Al Khateeb M S, Amr S S
Cancer Chemother Pharmacol. 1983;10(3):221-2. doi: 10.1007/BF00255768.
Five patients, three males and two females, with angioimmunoblastic lymphadenopathy (AIL) are described. The two who received steroids had no response and died 2 and 6 months later. The three patients who received vincristine, adriamycin and prednisolone (VAP) went into remission early and are still in remission with a follow-up of 22-35 months. It is concluded that VAP is effective therapy in AIL.